Targeting senescent cells alleviates obesity-induced metabolic dysfunction

Area of Science:

• Metabolic research
• Cellular biology
• Immunology

Background:

• Adipose tissue inflammation and dysfunction link obesity to insulin resistance and diabetes.
• Cellular senescence, characterized by accumulating senescent cells, is observed in obesity but its direct role in diabetes pathogenesis is unproven.

Purpose of the Study:

• To investigate the pathogenic role of cellular senescence in obesity-related metabolic dysfunction.
• To evaluate the therapeutic potential of senolytic interventions in ameliorating metabolic and adipose tissue dysfunction.

Main Methods:

• Utilized drug-inducible "suicide" genes (p16^Ink4a promoter) and senolytic agents to reduce senescent cell burden in obese mice.
• Assessed metabolic parameters including glucose tolerance, insulin sensitivity, and inflammatory markers.
• Examined adipose tissue characteristics, immune cell infiltration (monocytes, macrophages), and organ function (kidney, heart).

Main Results:

• Senolytic interventions significantly improved glucose tolerance and insulin sensitivity in obese mice.
• Reduced circulating inflammatory mediators and promoted adipogenesis in adipose tissue.
• Prevented monocyte migration and decreased macrophage accumulation in adipose tissue, alongside improvements in microalbuminuria, podocyte function, and cardiac diastolic function.

Conclusions:

• Cellular senescence is a causal factor in obesity-induced inflammation and metabolic derangements.
• Senolytic agents demonstrate therapeutic promise for treating obesity-related metabolic dysfunction and associated complications.